Utility of cystatin C for renal function in amyotrophic lateral sclerosis

Acta Neurologica Scandinavica

Volumn 128, Issue 6, 2013, Pages 386-390

  Tetsuka, S ^a   Morita, M ^a   Ikeguchi, K ^a   Nakano, I ^a  

^a JICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

Amyotrophic lateral sclerosis; Creatinine; Cystatin C; Estimated glomerular filtration rates; Renal function

Indexed keywords

CREATININE; CYSTATIN C;

ADULT; AMYOTROPHIC LATERAL SCLEROSIS; AMYOTROPHIC LATERAL SCLEROSIS FUNCTIONAL RATING SCALE; ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE SEVERITY; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; MUSCLE MASS; NEPHROTOXICITY; PROTEIN BLOOD LEVEL; RATING SCALE;

AMYOTROPHIC LATERAL SCLEROSIS; CREATININE; CYSTATIN C; ESTIMATED GLOMERULAR FILTRATION RATES; RENAL FUNCTION;

AGED; AMYOTROPHIC LATERAL SCLEROSIS; CREATININE; CYSTATIN C; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; KIDNEY DISEASES; LINEAR MODELS; MALE; MIDDLE AGED; SEVERITY OF ILLNESS INDEX;

EID: 84886639412     PISSN: 00016314     EISSN: 16000404     Source Type: Journal    
DOI: 10.1111/ane.12134     Document Type: Article

References (31)

1. del Aguila MA, Longstreth WT Jr, McGuire V, Koepsell TD, van Belle G. Prognosis in amyotrophic lateral sclerosis: a population-based study. Neurology 2003;60:813-9.
2. Hayashi H, Oppenheimer EA. ALS patients on TPPV: totally locked-in state, neurologic findings and ethical implications. Neurology 2003;61:135-7.
3. Mazzini L, Corra T, Zaccala M, Mora G, Del Piano M, Galante M. Percutaneous endoscopic gastrostomy and enteral nutrition in amyotrophic lateral sclerosis. J Neurol 1995;242:695-8.
4. Mathew TH, Johnson DW, Jones GR. Chronic kidney disease and automatic reporting of estimated glomerular filtration rate: revised recommendations. Med J 2007;187:459-63.
5. Newman DJ. Cystatin C. Ann Clin Biochem 2002;39:89-104.
6. Twomey PJ, Reynolds TM. The MDRD formula and validation. Q J Med 2006;99:804-5.
7. Rule AD, Larson TS, Bergstralh EJ, Slezak JM, Jacobsen SJ, Cosio FG. Using serum creatinine to estimate glomerular filtration rate: accuracy in good health and in chronic kidney disease. Ann Intern Med 2004;141:929-37.
8. Milic R, Colombini A, Lombardi G, Lanteri P, Banfi G. Estimation of glomerular filtration rate by MDRD equation in athletes: role of body surface area. Eur J Appl Physiol 2012;112:201-6.
9. Griggs RC, Forbes G, Moxley RT, Herr BE. The assessment of muscle mass in progressive neuromuscular disease. Neurology 1983;33:158-65.
10. Viollet L, Gailey S, Thornton DJ et al. Utility of cystatin C to monitor renal function in Duchenne muscular dystrophy. Muscle Nerve 2009;40:438-42.
11. Horio M, Imai E, Yasuda Y, Hishida A, Matsuo S. Simple sampling strategy for measuring inulin renal clearance. Clin Exp Nephrol 2009;13:50-4.
12. Piepsz A, Tondeur M, Ham H. Escaping the correction for body surface area when calculating glomerular filtration rate in children. Eur J Nucl Med Mol Imaging 2008;35:1669-72.
13. Abrahamson M, Olafsson I, Palsdottir A et al. Structure and expression of the human cystatin C gene. Biochem J 1990;268:287-94.
14. Filler G, Bokenkamp A, Hofmann W, Le Bricon T, Martinez-Bru C, Grubb A. Cystatin C as a marker of GFR-history, indications, and future research. Clin Biochem 2005;38:1-8.
15. Vinge E, Lindergard B, Nilsson-Ehle P, Grubb A. Relationships among serum cystatin C, serum creatinine, lean tissue mass and glomerular filtration rate in healthy adults. Scand J Clin Lab Invest 1999;59:587-92.
16. Brooks BR, Miller RG, Swash M, Munsat TL. World federation of neurology research group on motor neuron diseases. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord 2000;1:293-9.
17. Du Bois D, Du Bois EF. A formula to estimate the approximate surface area if height and weight be known. Arch Intern Med 1916;17:863-71.
18. Cedarbaum JM, Stambler N, Malta E et al. The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function. BDNFALS Study Group (Phase III). J Neurol Sci 1999;169:13-21.
19. Tanaka M, Matsuo K, Enomoto M, Mizuno K. A sol particle homogeneous immunoassay for measuring serum cystatin C. Clin Biochem 2004;37:27-35.
20. Matsuo S, Imai E, Horio M et al. Collaborators developing the Japanese equation for estimated GFR. Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis 2009;53:982-92.
21. Rule A, Bergstralh EJ, Slezak JM, Bergert J, Larson TS. Glomerular filtration rate estimated by cystatin C among different clinical presentation. Kidney Int 2006;69:399-405.
22. Gorson KC. Approach to neuromuscular disorders in the intensive care unit. Neurocrit Care 2005;3:195-212.
23. Simmons Z, Specht CS. The neuromuscular manifestations of amyloidosis. J Clin Neuromuscul Dis 2010;11:145-57.
24. Foster J, Reisman W, Lepage N, Filler G. Influence of commonly used drugs on the accuracy of cystatin C-derived glomerular filtration rate. Pediatr Nephrol 2006;21:235-8.
25. Holmquist P, Torffvit O, Sjoblad S. Metabolic status in diabetes mellitus affects markers for glomerular filtration rate. Pediatr Nephrol 2003;18:536-40.
26. Wiesli P, Schwegler B, Spinas GA, Schmid C. Serum cystatin C is sensitive to small changes in thyroid function. Clin Chim Acta 2003;338:87-90.
27. Kos J, Stabuc B, Cimerman N, Brünner N. Serum cystatin C, a new marker of glomerular filtration rate, is increased during malignant progression. Clin Chem 1998;44:2556-7.
28. Mauss S, Berger F, Kuschak D et al. Cystatin C as a marker of renal function is affected by HIV replication leading to an underestimation of kidney function in HIV patients. Antivir Ther 2008;13:1091-5.
29. Bokenkamp A, Domanetzki M, Zinck R, Schumann G, Byrd D, Brodehl J. Cystatin C-a new marker of glomerular filtration rate in children independent of age and height. Pediatrics 1998;101:875-81.
30. Newman DJ, Thakkar H, Edwards RG et al. Serum cystatin C measured by automated immunoassay: a more sensitive marker of changes in GFR than serum creatinine. Kidney Int 1995;47:312-8.
31. Jenkins MA, Brown DJ, Ierino FL, Ratnaike SI. Cystatin C for estimation of glomerular filtration rate in patients with spinal cord injury. Ann Clin Biochem 2003;40:364-8.